Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc monthly Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-21.63 Insider Own0.10% Shs Outstand329.24M Perf Week-1.62%
Market Cap53.72B Forward P/E9.55 EPS next Y17.09 Insider Trans0.54% Shs Float326.90M Perf Month27.31%
Income-7232.60M PEG- EPS next Q4.31 Inst Own92.10% Short Float1.43% Perf Quarter16.29%
Sales15.71B P/S3.42 EPS this Y24.90% Inst Trans4.04% Short Ratio1.12 Perf Half Y4.22%
Book/sh185.37 P/B0.88 EPS next Y2.59% ROA-7.00% Target Price181.32 Perf Year-7.22%
Cash/sh5.42 P/C30.12 EPS next 5Y3.03% ROE-10.80% 52W Range114.27 - 197.00 Perf YTD22.07%
Dividend2.96 P/FCF12.89 EPS past 5Y-36.00% ROI-4.80% 52W High-17.18% Beta1.64
Dividend %1.81% Quick Ratio0.60 Sales past 5Y43.40% Gross Margin86.20% 52W Low42.78% ATR3.62
Employees16900 Current Ratio0.70 Sales Q/Q-2.00% Oper. Margin-49.00% RSI (14)62.40 Volatility1.26% 1.62%
OptionableYes Debt/Eq0.38 EPS Q/Q-629.90% Profit Margin-45.90% Rel Volume0.59 Prev Close162.05
ShortableYes LT Debt/Eq0.32 EarningsAug 06 BMO Payout- Avg Volume4.17M Price163.16
Recom2.30 SMA201.65% SMA5014.68% SMA2008.58% Volume2,476,091 Change0.68%
Jul-18-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-16-19Downgrade Bernstein Outperform → Mkt Perform
Jun-11-19Initiated Barclays Underweight $133
May-28-19Initiated Goldman Neutral
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Jul-19-19 04:58PM  The 3 Top Stocks for Dividends Every Calendar Month
04:57PM  Is a Beat in the Cards for Bristol-Myers (BMY) Q2 Earnings? Zacks
09:53AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus Zacks
07:30AM  Allergan Declares Third Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire
Jul-18-19 11:00PM  Amgen And Allergan's MVASI (bevacizumab-awwb) And KANJINTI (trastuzumab-anns) Now Available In The United States PR Newswire
06:26PM  Allergan Announces FDA Acceptance of Glaucoma Candidate NDA Zacks
11:11AM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
10:33AM  Allergan (AGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
Jul-17-19 03:04PM  Hagens Berman: Federal Judge Greenlights Class-Action Antitrust Lawsuit Against Allergan Subsidiaries for Loestrin 24, Minastrin and Generics Business Wire
01:12PM  The Top 5 Buys of the T Rowe Price Equity Income Fund
07:30AM  U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension PR Newswire
Jul-16-19 05:50PM  Allergan (AGN) Dips More Than Broader Markets: What You Should Know Zacks
04:19PM  Is a Beat in the Cards for Novartis' (NVS) Q2 Earnings? Zacks
04:09PM  AbbVie Buys Allergan for $63 Billion Meredith Videos
09:49AM  Allergan Stock Wont Rise Much More, Analyst Says, in Looking at Deal With AbbVie
09:36AM  Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA Zacks
Jul-14-19 11:10AM  Health companies start reporting earnings next week: Here are 3 things to keep in mind MarketWatch
09:00AM  Is Allergan a Buy? Motley Fool
Jul-12-19 08:24PM  Investor Rights Alert: Halper Sadeh LLP Continues Investigating Whether the Sale of These Companies is Fair to Shareholders; Investors Are Encouraged to Contact the Firm DFRG, RTEC, PCMI, AGN GlobeNewswire
Jul-11-19 07:53AM  J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store? Zacks
Jul-10-19 05:50PM  Allergan (AGN) Gains But Lags Market: What You Should Know Zacks
04:53PM  Longleaf Partners Comments on Allergan
01:44PM  Longleaf Partners Fund's 2nd-Quarter Commentary
08:14AM  Will Patent Woes Boost Pharma Stock Megamergers Further? Zacks
Jul-09-19 03:55PM  Federal judge blocks Trump Administration's proposal to include wholesale drug prices in TV ads Yahoo Finance Video
09:45AM  Intra-Cellular Therapies' Candidate Fails in Phase III Study Zacks
08:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
07:41AM  Allergan Continues to Demonstrate Leadership in Migraine with 29 Presentations at the 2019 American Headache Society Annual Meeting PR Newswire
Jul-08-19 06:03PM  3 Dividend Stocks Retirees Must Have in Their Portfolios
09:41AM  AbbVie (ABBV) Shares Down So Far This Year: Here's Why Zacks
Jul-05-19 08:57AM  Editas (EDIT) Focuses on Developing Eye Candidate EDIT-101 Zacks
Jul-04-19 12:35PM  Why AbbVie's Stock Sank in the First Half of 2019 Motley Fool
07:04AM  3 Dividend Stocks That Pay You More Than Exxon Does Motley Fool
Jul-03-19 05:50PM  Allergan (AGN) Gains But Lags Market: What You Should Know Zacks
02:48PM  Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Oritani, Allergan, NRC, and Shore Community Bank on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
10:10AM  Can Allergan (AGN) Keep the Earnings Surprise Streak Alive? Zacks
09:34AM  Will the Pharma Space Witness More Mega-Merger Deals in 2H? Zacks
Jul-02-19 05:08PM  Is AbbVie a Buy? Motley Fool
10:43AM  AbbVies Allergan Acquisition Sowed Doubts on Wall Street. Some Analysts Are Coming Around.
Jul-01-19 08:58AM  Email API Platforms Gather Steam: VG, TWLO and AMZN in View Zacks
Jun-30-19 10:00AM  Barron's Picks And Pans: AbbVie, Crocs, RealReal, Roku And More Benzinga
07:00AM  4 Reasons to Buy AbbVie Now That It's Acquiring Allergan Motley Fool
Jun-28-19 08:00PM  For Apple, China Is an Irritant, and Wind of Opportunity
08:00PM  AbbVie Is Buying Allergan. Thats Not the Right Remedy for the Stock.
06:25PM  After AbbVie Stock Crashed, Three Insiders Loaded Up on Shares
12:05PM  4 Lower-Risk Healthcare Picks for Long-Term Investors Motley Fool
10:17AM  Are AbbVie and Allergan Really Better Together? Motley Fool
09:44AM  Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger Zacks
07:00AM  Almost $500 Billion of Megadeals Get Panned Instantly Bloomberg
Jun-27-19 09:47AM  Big Pharma Gets Bigger Motley Fool
05:20AM  Price of these promising drug-related stocks shows investors are too cautious about the healthcare sector MarketWatch
Jun-26-19 05:51PM  Is Allergan a Good Deal for AbbVie? Zacks
04:40PM  AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential
04:32PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Allergan plc (NYSE: AGN) on Behalf of Allergan Shareholders and Encourages Allergan Investors to Contact the Firm GlobeNewswire
04:18PM  Balancing Ethics With Returns
04:17PM  AbbVie Is 'The New Cash King' As It Takes On Botox-Maker Allergan Investor's Business Daily
12:31PM  Legal Investigation Alert: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders AGN, DFRG, PCMI, RTEC GlobeNewswire
12:26PM  Elliott Management Advocated for an Allergan Split Prior to Sale Bloomberg
11:00AM  Big Pharma Has to Bet Big on M&A. Investors Dont. Bloomberg
11:00AM  AbbVie to Buy Allergan: Prescribed ETFs Zacks
10:12AM  Company News For Jun 26, 2019 Zacks
09:26AM  AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal Zacks
09:22AM  The Zacks Analyst Blog Highlights: AbbVie, Allergan, Bristol-Myers and Celgene Zacks
09:13AM  Here's Why Nobody's Happy About This $63 Billion Buyout Motley Fool
09:07AM  AbbVie Stock Is Rising as Some See Considerable Opportunity in Selloff
08:58AM  AbbVie's Allergan Deal Sets Up Another Trade In Big Biotech
07:37AM  Allergan acquisition is a major bailout for shareholders, according to analysts MarketWatch
02:46AM  Stocks - Futures Surge as Mnuchin says U.S.-China Trade Deal 90% Complete
Jun-25-19 11:17PM  Replay: What to Watch in The Markets: AbbVie-Allergan, Micron, Buffett, and More +25.36%
06:05PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Allergan Plc PR Newswire
05:33PM  US Stock Market Overview – Stocks Drop on US/Iran Conflict FX Empire
05:33PM  Surging Allergan Stock Is Approaching AbbVies Bid Price
05:02PM  What Happened in the Stock Market Today Motley Fool
04:21PM  Dow Ends Lower, Stocks Fall as Powell Says Fed 'Grappling' with Rate Cut
04:19PM  Axsome Initiates Phase III Study on Depression Candidate Zacks
04:15PM  AbbVie + Allergan: Where Are The Synergies? Zacks
04:11PM  Nasdaq records three-day losing streak after Powell emphasizes wait-and-see stance on rates MarketWatch
04:10PM  Pharma Buying Spree Continues As AbbVie Takes Out Allergan For $63 Billion Investor's Business Daily
04:05PM  Abbvie Drops by a Record as Allergan Deal Fails to End Doubts Bloomberg
03:01PM  AbbVie (ABBV) Stock Falls After $63 Billion Allergan Acquisition Announcement Zacks
02:58PM  Allergan Options Bull Wins Big on AbbVie Buyout Buzz Schaeffer's Investment Research
02:05PM  AbbVie Shareholders Will Get No Vote on Purchase of Allergan
01:58PM  Allergan Finance, LLC -- Moody's reviews Allergan's Baa3 ratings for upgrade Moody's
12:38PM  Wall Street Voices Skepticism on AbbVie's Aggressive Allergan Acquisition
12:37PM  AbbVie Buys Allergan for Over $60 Billion
12:28PM  Stock Market News: AbbVie Bets Big; Can Microsoft Stay on Top? Motley Fool
12:23PM  AbbVie Gets a Shot in the Arm With Allergan Buy, but Now Look Elsewhere
12:10PM  AbbVies $63 Billion Mega Deal Returns Focus to Debt-Fueled M&A Bloomberg
12:08PM  AbbVie's $18 Billion Blowup Brings Deal Deja Vu to Some Holders Bloomberg
12:03PM  AbbVie Is Buying Allergan. Wall Street Has Doubts.
11:53AM  US STOCKS-Wall St dragged down by Iran tensions, trade worries; Fed in focus Reuters
11:46AM  AbbVie Buys Allergan for $63 Billion: Was the Price Just Right?
11:36AM  Allergan Agrees to $63 Billion Takeover From AbbVie in Blockbuster Pharma Deal
11:30AM  Why AbbVie Stock Is Sinking and Allergan Is Soaring Today Motley Fool
11:17AM  AbbVie looks beyond Humira with $63 bln deal for Botox-maker Allergan Reuters
11:14AM  Shares of Botox Maker Allergan Get a Lift
11:14AM  I Believe AbbVie and Allergen Need Each Other
11:12AM  AbbVie Stocks Already Big Dividend Yield Is Getting a Boost From Its Deal for Allergan
11:09AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Allergan plc to AbbVie Inc. is Fair to Shareholders GlobeNewswire
11:03AM  Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; and strategic alliance and option agreement with Editas Medicine, Inc. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM